Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margot J Whitfeld

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
BMC Infectious Diseases|September 15, 2019
Prevalence of scabies and impetigo in the Solomon Islands: a school surveyMillicent H Osti, Oliver Sokana, Sophie Phelan, et al.
The New England Journal of Medicine|December 10, 2015
Mass Drug Administration for Scabies Control in a Population with Endemic DiseaseLucia Romani, Margot J Whitfeld, Josefa Koroivueta, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|June 28, 2021
Health-related quality of life impact of scabies in the Solomon IslandsSusanna J Lake, Daniel Engelman, Oliver Sokana, et al.
The Lancet. Global Health|September 19, 2018
Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trialLucia Romani, Michael Marks, Oliver Sokana, et al.
The American Journal of Tropical Medicine and Hygiene|July 20, 2017
The Epidemiology of Scabies and Impetigo in Relation to Demographic and Residential Characteristics: Baseline Findings from the Skin Health Intervention Fiji TrialLucia Romani, Margot J Whitfeld, Josefa Koroivueta, et al.
The Lancet. Infectious Diseases|April 9, 2019
Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trialLucia Romani, Michael Marks, Oliver Sokana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2019
Prevalence of Scabies and Impetigo 3 Years After Mass Drug Administration With Ivermectin and AzithromycinMichael Marks, Lucia Romani, Oliver Sokana, et al.
Plos Neglected Tropical Diseases|March 17, 2020
The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trialMyra Hardy, Josaia Samuela, Mike Kama, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2021
Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized TrialMyra Hardy, Josaia Samuela, Mike Kama, et al.
Plos Neglected Tropical Diseases|February 22, 2021
Defining the need for public health control of scabies in Solomon IslandsSusanna J Lake, Daniel Engelman, Oliver Sokana, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
BMC Infectious Diseases|September 15, 2019
Prevalence of scabies and impetigo in the Solomon Islands: a school surveyMillicent H Osti, Oliver Sokana, Sophie Phelan, et al.
The New England Journal of Medicine|December 10, 2015
Mass Drug Administration for Scabies Control in a Population with Endemic DiseaseLucia Romani, Margot J Whitfeld, Josefa Koroivueta, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|June 28, 2021
Health-related quality of life impact of scabies in the Solomon IslandsSusanna J Lake, Daniel Engelman, Oliver Sokana, et al.
The Lancet. Global Health|September 19, 2018
Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trialLucia Romani, Michael Marks, Oliver Sokana, et al.
The American Journal of Tropical Medicine and Hygiene|July 20, 2017
The Epidemiology of Scabies and Impetigo in Relation to Demographic and Residential Characteristics: Baseline Findings from the Skin Health Intervention Fiji TrialLucia Romani, Margot J Whitfeld, Josefa Koroivueta, et al.
The Lancet. Infectious Diseases|April 9, 2019
Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trialLucia Romani, Michael Marks, Oliver Sokana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2019
Prevalence of Scabies and Impetigo 3 Years After Mass Drug Administration With Ivermectin and AzithromycinMichael Marks, Lucia Romani, Oliver Sokana, et al.
Plos Neglected Tropical Diseases|March 17, 2020
The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trialMyra Hardy, Josaia Samuela, Mike Kama, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2021
Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized TrialMyra Hardy, Josaia Samuela, Mike Kama, et al.
Plos Neglected Tropical Diseases|February 22, 2021
Defining the need for public health control of scabies in Solomon IslandsSusanna J Lake, Daniel Engelman, Oliver Sokana, et al.
Pageof 3